(Q46937612)

26 December 2017

title

Treatment of Peyronie's disease with oral pentoxifylline (English)

1 reference

26 December 2017

1 reference

William O Brant

1

1 reference

26 December 2017

Robert C Dean

series ordinal

2

1 reference

26 December 2017

Tom F Lue

series ordinal

3

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

26 December 2017

published in

Nature Reviews Urology

1 reference

26 December 2017

volume

3

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

111-5; quiz 116

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/ncpuro0409

exact match

0 references

cites work

Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

The prevalence of Peyronie's disease: results of a large survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Peyronie's disease: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

The Natural History of Peyronie’s Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

The natural history of Peyronie's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Trauma as the cause of Peyronie's disease: penile fracture as a model of trauma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Establishing a standardized evaluation of the man with Peyronie's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Diagnostic value of magnetic resonance imaging in Peyronie's disease--a comparison both with palpation and ultrasound in the evaluation of plaque formation

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Case report: resolution of symptomatic epidural fibrosis following treatment with combined pentoxifylline-tocopherol.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Histopathological effects of sildenafil citrate on rat corpus cavernosum

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0409

7 January 2021

Identifiers

DOI

10.1038/NCPURO0409

1 reference

26 December 2017

1 reference

26 December 2017